Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Cantor Fitzgerald on Anticipated Milvexian Pressure

October 8, 2026 7:12 AM
Cantor Fitzgerald analyst Carter Gould lowered the price target on Bristol-Myers Squibb Co ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change